ArticleThe Lancet. Oncology2012

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.

David Olmos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.